| Dr Shanna Marie Howard, PHARMD | |
|
790 Schillinger Rd S, T-1376, Mobile, AL 36695-8979 | |
| (251) 776-1512 | |
| Not Available |
| Full Name | Dr Shanna Marie Howard |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 790 Schillinger Rd S, Mobile, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255610960 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 16825 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Shanna Marie Howard, PHARMD 790 Schillinger Rd S, T-1376, Mobile, AL 36695-8979 Ph: (251) 776-1512 | Dr Shanna Marie Howard, PHARMD 790 Schillinger Rd S, T-1376, Mobile, AL 36695-8979 Ph: (251) 776-1512 |
News Archive
After weeks of painstaking talks, Democrats celebrated breakthroughs on health care overhaul on both sides of the Capitol. Yet many lawmakers and health care experts said that yesterday's events marked only one step on the very bumpy road to a final deal that President Barack Obama might sign into law.
Eye-opening research by neurosurgeons from Barrow Neurological Institute and Montreal Neurological Institute has produced the foremost investigation of the origin and evolution of perhaps the most famous concept devised in neurobiology-the homunculus of neurosurgeon Wilder Penfield.
Almac, a leading provider of contract services to the global pharmaceutical and biotech industries, responded earlier this year to an urgent request from their client partner, Alexion Pharmaceuticals, Inc., a global biotechnology company, for packaging and distribution of Soliris (eculizumab) for patients with STEC-HUS during the E. coli outbreak in Germany earlier this year.
An Andalusian team of researchers led by the University of Granada has demonstrated the efficacy of a new drug against cancerogenic stem cells, which cause the onset and development of cancer, of relapse after chemotherapy and metastasis. This drug, called Bozepinib, has proved to be effective in tests with mice.
A unique survey of African American breast cancer survivors at heightened risk for hereditary breast cancer has found the majority do not believe they have an increased chance of developing the cancer again.
› Verified 6 days ago
Dr. Wilfred Arcard Brown, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3948 Airport Blvd, Mobile, AL 36608 Phone: 251-345-3394 | |
Chidiya Ohiagu, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1303 Dr Martin L King Jr Ave, Mobile, AL 36603 Phone: 251-432-4117 | |
Darren P Billiot, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6575 Airport Blvd, Mobile, AL 36608 Phone: 251-370-9848 | |
Eric Donaldson Reeves, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4628 Airport Blvd, Mobile, AL 36608 Phone: 251-341-5749 | |
Mr. Chuck P Whisonant, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1504 Spring Hill Ave, Mobile, AL 36604 Phone: 251-219-3754 | |
Ms. Angela F. Amos, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 251 N Bayou St, Mobile, AL 36603 Phone: 251-690-8817 | |
Dr. Raymond Lorenz, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2400 Gordon Smith Dr, Mobile, AL 36617 Phone: 251-450-1388 |